Modafinil, a wakefulness-selling agent, has gained important consideration in both clinical and non-clinical settings. Initially approved for the therapy of narcolepsy, obstructive sleep apnea, and shift work sleep disorder, modafinil has additionally change into well-liked off-label for its cognitive-enhancing results. This observational research article explores the availability and use of
